These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33729000)

  • 1. Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton.
    Hashmi SK; Ceron RH; Heuckeroth RO
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G919-G935. PubMed ID: 33729000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice.
    Halim D; Wilson MP; Oliver D; Brosens E; Verheij JB; Han Y; Nanda V; Lyu Q; Doukas M; Stoop H; Brouwer RW; van IJcken WF; Slivano OJ; Burns AJ; Christie CK; de Mesy Bentley KL; Brooks AS; Tibboel D; Xu S; Jin ZG; Djuwantono T; Yan W; Alves MM; Hofstra RM; Miano JM
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2739-E2747. PubMed ID: 28292896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.
    Moreno CA; Metze K; Lomazi EA; Bertola DR; Barbosa RH; Cosentino V; Sobreira N; Cavalcanti DP
    Am J Med Genet A; 2016 Nov; 170(11):2965-2974. PubMed ID: 27481187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Wangler MF; Gonzaga-Jauregui C; Gambin T; Penney S; Moss T; Chopra A; Probst FJ; Xia F; Yang Y; Werlin S; Eglite I; Kornejeva L; Bacino CA; Baldridge D; Neul J; Lehman EL; Larson A; Beuten J; Muzny DM; Jhangiani S; ; Gibbs RA; Lupski JR; Beaudet A
    PLoS Genet; 2014 Mar; 10(3):e1004258. PubMed ID: 24676022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous loss of function variants in MYL9 in a child with megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Kandler JL; Sklirou E; Woerner A; Walsh L; Cox E; Xue Y
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1516. PubMed ID: 33031641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-Function Variants in MYLK Cause Recessive Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.
    Halim D; Brosens E; Muller F; Wangler MF; Beaudet AL; Lupski JR; Akdemir ZHC; Doukas M; Stoop HJ; de Graaf BM; Brouwer RWW; van Ijcken WFJ; Oury JF; Rosenblatt J; Burns AJ; Tibboel D; Hofstra RMW; Alves MM
    Am J Hum Genet; 2017 Jul; 101(1):123-129. PubMed ID: 28602422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.
    Assia Batzir N; Kishor Bhagwat P; Larson A; Coban Akdemir Z; Bagłaj M; Bofferding L; Bosanko KB; Bouassida S; Callewaert B; Cannon A; Enchautegui Colon Y; Garnica AD; Harr MH; Heck S; Hurst ACE; Jhangiani SN; Isidor B; Littlejohn RO; Liu P; Magoulas P; Mar Fan H; Marom R; McLean S; Nezarati MM; Nugent KM; Petersen MB; Rocha ML; Roeder E; Smigiel R; Tully I; Weisfeld-Adams J; Wells KO; ; Posey JE; Lupski JR; Beaudet AL; Wangler MF
    Hum Mutat; 2020 Mar; 41(3):641-654. PubMed ID: 31769566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome.
    Gauthier J; Ouled Amar Bencheikh B; Hamdan FF; Harrison SM; Baker LA; Couture F; Thiffault I; Ouazzani R; Samuels ME; Mitchell GA; Rouleau GA; Michaud JL; Soucy JF
    Eur J Hum Genet; 2015 Sep; 23(9):1266-8. PubMed ID: 25407000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital mydriasis associated with megacystis microcolon intestinal hypoperistalsis syndrome.
    McClelland C; Walsh RD; Chikwava KR; Johnson MP; Mattei P; Liu GT
    J Neuroophthalmol; 2013 Sep; 33(3):271-5. PubMed ID: 23636104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in smooth muscle contractile and cytoskeleton proteins and interstitial cells of Cajal in megacystis microcolon intestinal hypoperistalsis syndrome.
    Piotrowska AP; Rolle U; Chertin B; De Caluwé D; Bianchi A; Puri P
    J Pediatr Surg; 2003 May; 38(5):749-55. PubMed ID: 12720186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological, Ultrastructural, and Immunohistochemical Findings in
    Kapur RP
    Pediatr Dev Pathol; 2023; 26(1):39-51. PubMed ID: 36571289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the complexities of megacystis-microcolon-intestinal hypoperistalsis syndrome: insights from genetic studies.
    Devavarapu PKV; Uppaluri KR; Nikhade VA; Palasamudram K; Sri Manjari K
    Clin J Gastroenterol; 2024 Jun; 17(3):383-395. PubMed ID: 38461165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Pathology in Patients With Pathogenic
    Kapur RP; Goldstein AM; Loeff DS; Myers CT; Paschal CR
    Pediatr Dev Pathol; 2022; 25(6):581-597. PubMed ID: 35695198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS): report of a case with prolonged survival and literature review.
    López-Muñoz E; Hernández-Zarco A; Polanco-Ortiz A; Villa-Morales J; Mateos-Sánchez L
    J Pediatr Urol; 2013 Feb; 9(1):e12-8. PubMed ID: 22749573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral myopathy diagnosed by a de novo
    Xiong X; Li J; Liu C; Xu F
    Transl Pediatr; 2021 Mar; 10(3):679-685. PubMed ID: 33880338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of voiding dysfunction in megacystis microcolon intestinal hypoperistalsis syndrome.
    Rolle U; Puri P
    J Pediatr Urol; 2006 Aug; 2(4):277-84. PubMed ID: 18947621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal dysmotility: An intrinsic feature of megacystis, microcolon, hypoperistalsis syndrome (MMIHS).
    Kocoshis SA; Goldschmidt ML; Nathan JD; El-Chammas KI; Bondoc AJ; Tiao GM; Alonso MH; Ubesie AC; Cole CR; Kaul A
    J Pediatr Surg; 2019 Jul; 54(7):1303-1307. PubMed ID: 30257810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.
    Ravenscroft G; Pannell S; O'Grady G; Ong R; Ee HC; Faiz F; Marns L; Goel H; Kumarasinghe P; Sollis E; Sivadorai P; Wilson M; Magoffin A; Nightingale S; Freckmann ML; Kirk EP; Sachdev R; Lemberg DA; Delatycki MB; Kamm MA; Basnayake C; Lamont PJ; Amor DJ; Jones K; Schilperoort J; Davis MR; Laing NG
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13371. PubMed ID: 29781137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTG2 variants impair actin polymerization in sporadic Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.
    Halim D; Hofstra RM; Signorile L; Verdijk RM; van der Werf CS; Sribudiani Y; Brouwer RW; van IJcken WF; Dahl N; Verheij JB; Baumann C; Kerner J; van Bever Y; Galjart N; Wijnen RM; Tibboel D; Burns AJ; Muller F; Brooks AS; Alves MM
    Hum Mol Genet; 2016 Feb; 25(3):571-83. PubMed ID: 26647307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.
    Matera I; Bordo D; Di Duca M; Lerone M; Santamaria G; Pongiglione M; Lezo A; Diamanti A; Spagnuolo MI; Pini Prato A; Alberti D; Mattioli G; Gandullia P; Ceccherini I
    Clin Genet; 2021 Mar; 99(3):430-436. PubMed ID: 33294969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.